Overview
Ryushi Tazawa practices in Tokyo, Japan. Tazawa is rated as an Advanced expert by MediFind in the treatment of Fabry Disease. Their top areas of expertise are Pulmonary Alveolar Proteinosis, Fabry Disease, Waardenburg Syndrome Type 2, and Lymphangioleiomyomatosis.
Their clinical research consists of co-authoring 46 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Fabry Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Pulmonary Alveolar Proteinosis
- Advanced
- Fabry DiseaseTazawa isAdvanced. Learn about Fabry Disease.
- Experienced
- Acute Interstitial PneumoniaTazawa isExperienced. Learn about Acute Interstitial Pneumonia.
- Interstitial Lung DiseaseTazawa isExperienced. Learn about Interstitial Lung Disease.
- LymphangioleiomyomatosisTazawa isExperienced. Learn about Lymphangioleiomyomatosis.
- Myelodysplastic Syndrome (MDS)Tazawa isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Waardenburg SyndromeTazawa isExperienced. Learn about Waardenburg Syndrome.
- Waardenburg Syndrome Type 1Tazawa isExperienced. Learn about Waardenburg Syndrome Type 1.